Matthew C. Abramowitz

1.8k total citations · 1 hit paper
88 papers, 1.2k citations indexed

About

Matthew C. Abramowitz is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Radiation. According to data from OpenAlex, Matthew C. Abramowitz has authored 88 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 36 papers in Radiology, Nuclear Medicine and Imaging and 29 papers in Radiation. Recurrent topics in Matthew C. Abramowitz's work include Prostate Cancer Diagnosis and Treatment (59 papers), Prostate Cancer Treatment and Research (43 papers) and Advanced Radiotherapy Techniques (29 papers). Matthew C. Abramowitz is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (59 papers), Prostate Cancer Treatment and Research (43 papers) and Advanced Radiotherapy Techniques (29 papers). Matthew C. Abramowitz collaborates with scholars based in United States, Canada and Australia. Matthew C. Abramowitz's co-authors include Alan Pollack, Radka Stoyanova, Alan Dal Pra, Eric M. Horwitz, Mark K. Buyyounouski, Eric A. Ross, Robert G. Uzzo, Kevin L. Stephans, Rahul D. Tendulkar and Jason A. Efstathiou and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer.

In The Last Decade

Matthew C. Abramowitz

83 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy

2016 229 citations Matthew C. Abramowitz, Alan Pollack et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew C. Abramowitz United States	19	915	411	301	143	120	88	1.2k
Constantinos Zamboglou Germany	23	1.2k 1.4×	791 1.9×	406 1.3×	181 1.3×	150 1.3×	100	1.7k
Ben Vanneste Netherlands	19	495 0.5×	280 0.7×	328 1.1×	202 1.4×	253 2.1×	73	923
Lucas C. Mendez Canada	17	350 0.4×	190 0.5×	261 0.9×	94 0.7×	168 1.4×	83	782
Gregor Goldner Austria	24	1.1k 1.2×	681 1.7×	979 3.3×	144 1.0×	361 3.0×	65	1.8k
Uwe Haverkamp Germany	18	361 0.4×	211 0.5×	242 0.8×	207 1.4×	174 1.4×	105	909
Takuyo Kozuka Japan	17	1.1k 1.2×	484 1.2×	595 2.0×	272 1.9×	291 2.4×	67	1.6k
Xinglei Shen United States	18	337 0.4×	223 0.5×	258 0.9×	550 3.8×	173 1.4×	72	1.5k
Michael Roach United States	18	1.0k 1.1×	828 2.0×	815 2.7×	443 3.1×	183 1.5×	70	1.7k
Houda Bahig Canada	22	751 0.8×	572 1.4×	460 1.5×	372 2.6×	220 1.8×	118	1.5k
Fernando Muñoz Italy	18	604 0.7×	283 0.7×	300 1.0×	230 1.6×	507 4.2×	75	1.0k

Countries citing papers authored by Matthew C. Abramowitz

Since Specialization

Citations

This map shows the geographic impact of Matthew C. Abramowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew C. Abramowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew C. Abramowitz more than expected).

Fields of papers citing papers by Matthew C. Abramowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew C. Abramowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew C. Abramowitz. The network helps show where Matthew C. Abramowitz may publish in the future.

Co-authorship network of co-authors of Matthew C. Abramowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew C. Abramowitz. A scholar is included among the top collaborators of Matthew C. Abramowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew C. Abramowitz. Matthew C. Abramowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Penny R., Nesrin Dogan, John C. Ford, et al.. (2025). Repeatability, reproducibility, and the effects of radiotherapy on radiomic features of lowfield MR-LINAC images of the prostate. Frontiers in Oncology. 14. 1408752–1408752. 2 indexed citations

Ford, John C., Matthew T. Studenski, Kyle R. Padgett, et al.. (2024). Increasing the efficiency of cone-beam CT based delta-radiomics using automated contours to predict radiotherapy-related toxicities in prostate cancer. Scientific Reports. 14(1). 9563–9563. 1 indexed citations

Rich, Benjamin, Deukwoo Kwon, Benjamin Spieler, et al.. (2024). A Smart Water Bottle and Companion App (HidrateSpark 3) to Improve Bladder-Filling Compliance in Patients With Prostate Cancer Receiving Radiotherapy: Nonrandomized Trial of Feasibility and Acceptability. JMIR Cancer. 10. e51061–e51061. 1 indexed citations

Algohary, Ahmad, Evangelia I. Zacharaki, Sandra M. Gaston, et al.. (2023). Uncovering prostate cancer aggressiveness signal in T2‐weighted MRI through a three‐reference tissues normalization technique. NMR in Biomedicine. 37(3). e5069–e5069. 2 indexed citations

Bell, Jonathan B., Mohammed Goryawala, Gregory Azzam, et al.. (2023). Delineation of recurrent glioblastoma by whole brain spectroscopic magnetic resonance imaging. Radiation Oncology. 18(1). 37–37. 6 indexed citations

Stoyanova, Radka, Olmo Zavala‐Romero, Deukwoo Kwon, et al.. (2023). Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI. Cancers. 15(21). 5240–5240. 3 indexed citations

Alshalalfa, Mohammed, Idalid Franco, Randy Vince, et al.. (2022). Clinicogenomic characterization of prostate cancer liver metastases. Prostate Cancer and Prostatic Diseases. 25(2). 366–369. 13 indexed citations

Rich, Benjamin, Benjamin Spieler, Brandon A. Mahal, et al.. (2022). Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 114(4). 718–724. 4 indexed citations

Ford, John C., Kyle R. Padgett, Matthew T. Studenski, et al.. (2021). Assessment of CT to CBCT contour mapping for radiomic feature analysis in prostate cancer. Scientific Reports. 11(1). 22737–22737. 7 indexed citations

10.

Stoyanova, Radka, Alan Dal Pra, Matthew C. Abramowitz, et al.. (2020). Post-Treatment Biopsy Positivity In Prostate Cancer Patients Undergoing MpMRI-Targeted Radiation Dose Escalation. International Journal of Radiation Oncology*Biology*Physics. 108(3). e870–e870. 1 indexed citations

11.

Ford, John C., et al.. (2020). The role of radiomics in prostate cancer radiotherapy. Strahlentherapie und Onkologie. 196(10). 900–912. 28 indexed citations

12.

Studenski, Matthew T., et al.. (2019). Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume. Medical dosimetry. 44(4). 405–408. 4 indexed citations

13.

Eade, Thomas, Ananya Choudhury, Alan Pollack, et al.. (2018). Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort Study. International Journal of Radiation Oncology*Biology*Physics. 101(4). 957–963. 6 indexed citations

14.

Stoyanova, Radka, Deukwoo Kwon, Isildinha M. Reis, et al.. (2018). An Automated Multiparametric MRI Quantitative Imaging Prostate Habitat Risk Scoring System for Defining External Beam Radiation Therapy Boost Volumes. International Journal of Radiation Oncology*Biology*Physics. 102(4). 821–829. 19 indexed citations

15.

Pollack, Alan, Sanoj Punnen, John C. Ford, et al.. (2018). Automatic Detection of Prostate Tumor Habitats using Diffusion MRI. Scientific Reports. 8(1). 16801–16801. 10 indexed citations

16.

Parra, Nestor A., Alan Pollack, Matthew C. Abramowitz, et al.. (2017). Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness. Frontiers in Oncology. 7. 259–259. 15 indexed citations

17.

Johnson, Skyler B., Pamela R. Soulos, Timothy D. Shafman, et al.. (2016). Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E242–E242. 1 indexed citations

18.

Saigal, Kunal, Edgardo S. Santos, Khaled Tolba, et al.. (2014). Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 4. 165–165. 7 indexed citations

19.

Abramowitz, Matthew C., Tianyu Li, Monica Morrow, et al.. (2010). History of Smoking is Associated with Younger Age at Diagnosis of Breast Cancer. The Breast Journal. 16(4). 344–9. 9 indexed citations

20.

Abramowitz, Matthew C. & Alan Pollack. (2008). Postprostatectomy Radiation Therapy for Prostate Cancer. Seminars in Radiation Oncology. 18(1). 15–22. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact